REDS — Redsense Medical AB (publ) Cashflow Statement
0.000.00%
Last trade - 00:00- SEK49.66m
- SEK42.31m
- SEK24.02m
Annual cashflow statement for Redsense Medical AB (publ), fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -7.97 | -8.76 | -4.51 | 0.342 | -7.17 |
| Non-Cash Items | -2.12 | -0.03 | -1.52 | -1.02 | 2.47 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | -2.13 | -0.995 | 0.979 | -7.55 | -5.22 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -12.2 | -9.78 | -5.05 | -8.23 | -9.93 |
| Capital Expenditures | -0.36 | -0.048 | -0.052 | -0.611 | -2.79 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -9.35 | 10.9 | 8.4 | 0 | 0 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Change in Net Intangibles | |||||
| Cash from Investing Activities | -9.71 | 10.9 | 8.35 | -0.611 | -2.79 |
| Financing Cash Flow Items | — | 0.001 | — | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -1.89 | -2.4 | 0 | 17.2 | 0.017 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -24 | -1.31 | 3.29 | 8.39 | -8 |